PK/PD modelling to advance the preclinical development of a novel polymer prodrug in oncology
Résumé
Background pharmacodynamics medthods :
Taxanes such as Paclitaxel (PTX) are considered essential chemotherapeutics for the treatment of solid tumors. PTX formulations have been explored to increase efficacy, to reduce toxicities and have improved pharmacokinetics (PK).
Treatment simulation - Results - Outline - PK/PD modeling: dose regimen optimization
Origine | Fichiers produits par l'(les) auteur(s) |
---|